DEBBIE MARTINEZ: Open Payments
NPI 1154554343 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 35 payments from 14 companies in 2025. Trend: 2023 $474 · 2024 $515 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $168 |
| Dexcom, Inc. | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Novo Nordisk Inc | 3 | $58 |
| Medtronic, Inc. | 1 | $49 |
| Lilly USA, LLC | 2 | $45 |
| Mannkind Corporation | 1 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: OTEZLA, Dexcom G6 Transmitter, Kerendia, CATALYFT PL EXPANDABLE INTERBODY SYSTEM, Repatha, MOUNJARO, AFREZZA, GVOKE HYPOPEN.
Industry payments across TX — which companies pay providers there.
